(Q46200583)

20 December 2017

title

Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients (English)

1 reference

20 December 2017

author name string

Hala O El-Mesallamy

series ordinal

1

1 reference

20 December 2017

Nadia M Hamdy

series ordinal

2

1 reference

20 December 2017

Al-aliaa M Sallam

series ordinal

3

1 reference

20 December 2017

publication date

4 February 2012

1 reference

20 December 2017

published in

Acta Diabetologica

1 reference

20 December 2017

volume

50

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

page(s)

679-685

1 reference

20 December 2017

Serum retinol-binding protein 4 is associated with insulin secretion in Chinese people with normal glucose tolerance

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Retinol binding protein 4 and insulin resistance in apparently healthy elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Retinol-binding protein 4 in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1beta: a proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Molecular interactions of the IGF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Unraveling insulin-like growth factor binding protein-3 actions in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Obesity and type 2 diabetes: what can be unified and what needs to be individualized?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-alpha induced apoptosis and signalling in beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

IGF-I- and IGFBP-3-expression in cultured human preadipocytes and adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0373-6

Determination of the glycosylated hemoglobins (HB AI) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIAB.27.9.931

Identifiers

DOI

10.1007/S00592-012-0373-6

1 reference

20 December 2017

1 reference

20 December 2017